Kenneth Ian Weissman - 07 Mar 2026 Form 4 Insider Report for IMAX CORP (IMAX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
10 Mar 2026, 16:20:09 UTC
Prior SEC filing
14 Aug 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Kenneth Ian Weissman

Key filing fact

Kenneth Ian Weissman filed Form 4 for IMAX CORP (IMAX) on 10 Mar 2026.

Key facts

  • This page summarizes Kenneth Ian Weissman's Form 4 filing for IMAX CORP (IMAX).
  • 10 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 10 Mar 2026, 16:20.

Change

  • Previous filing in this sequence was filed on 14 Aug 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001727718 Primary reporting owner

Weissman Kenneth Ian

Relationship
Deputy GC, Corp. Sec. & CCO
Address
902 BROADWAY, 20TH FLOOR, NEW YORK
Signature
Kenneth Ian Weissman
Signature date
10 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IMAX transaction

common shares

Options Exercise

Transaction value
Shares
+3,619
Change %
+14%
Price
$0.000000*
Shares after
29,752
Date
07 Mar 2026
Ownership
Direct
Footnotes
F1
IMAX transaction

common shares

Options Exercise

Transaction value
Shares
+4,001
Change %
+13%
Price
$0.000000*
Shares after
33,753
Date
07 Mar 2026
Ownership
Direct
Footnotes
F1
IMAX transaction

common shares

Options Exercise

Transaction value
Shares
+1,800
Change %
+5.3%
Price
$0.000000*
Shares after
35,553
Date
07 Mar 2026
Ownership
Direct
Footnotes
F1
IMAX transaction

common shares

Tax liability

Transaction value
Shares
-3,397
Change %
-9.6%
Price
$40.80*
Shares after
32,156
Date
07 Mar 2026
Ownership
Direct
Footnotes
F2
IMAX transaction

common shares

Award

Transaction value
Shares
+6,333
Change %
+20%
Price
$0.000000*
Shares after
38,489
Date
07 Mar 2026
Ownership
Direct
Footnotes
F3
IMAX transaction

common shares

Tax liability

Transaction value
Shares
-2,284
Change %
-5.9%
Price
$40.80*
Shares after
36,205
Date
07 Mar 2026
Ownership
Direct
Footnotes
F4
IMAX holding

common shares (opening balance)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
26,133
Date
07 Mar 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IMAX transaction Derivative

restricted share units

Options Exercise

Transaction value
Shares
-3,619
Change %
-100%
Price
$0.000000*
Shares after
0
Date
07 Mar 2026
Ownership
Direct
Underlying class
common shares
Underlying amount
3,619
Exercise price
$0.000000
Footnotes
F1, F5, F6, F7, F11
IMAX transaction Derivative

restricted share units

Options Exercise

Transaction value
Shares
-4,001
Change %
-50%
Price
$0.000000*
Shares after
4,001
Date
07 Mar 2026
Ownership
Direct
Underlying class
common shares
Underlying amount
4,001
Exercise price
$0.000000
Footnotes
F1, F5, F6, F8, F11
IMAX transaction Derivative

restricted share units

Options Exercise

Transaction value
Shares
-1,800
Change %
-33%
Price
$0.000000*
Shares after
3,600
Date
07 Mar 2026
Ownership
Direct
Underlying class
common shares
Underlying amount
1,800
Exercise price
$0.000000
Footnotes
F1, F5, F6, F9, F11
IMAX transaction Derivative

restricted share units

Award

Transaction value
Shares
+3,652
Change %
Price
$0.000000*
Shares after
3,652
Date
07 Mar 2026
Ownership
Direct
Underlying class
common shares
Underlying amount
3,652
Exercise price
$0.000000
Footnotes
F5, F6, F10, F11
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 11 footnotes

Footnote F1

Represents the conversion upon vesting of restricted share units into common shares.

Footnote F2

Mr. Weissman is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligations in connection with the delivery of common shares upon conversion of the restricted share unit transactions.

Footnote F3

Represents the conversion of vested performance stock units into common shares granted by the Company on March 7, 2023. The shares earned are based on the level of achievement on the EBITDA performance conditions over the three year performance period.

Footnote F4

Mr. Weissman is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligations in connection with the delivery of common shares upon conversion of the performance stock unit transactions.

Footnote F5

Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation.

Footnote F6

Each restricted share unit is the economic equivalent of one common share of IMAX Corporation.

Footnote F7

The restricted share units vest and will be converted to common shares in three equal installments: 3,619 on each of March 7, 2024, March 7, 2025 and March 7, 2026.

Footnote F8

The restricted share units vest and will be converted to common shares in three equal installments: 4,001 on each of March 7, 2025, March 7, 2026 and March 7, 2027.

Footnote F9

The restricted share units vest and will be converted to common shares in three equal installments: 1,800 on each of March 7, 2026, March 7, 2027 and March 7, 2028.

Footnote F10

The restricted share units vest and will be converted to common shares in three installments: 1,217 on each of March 7, 2027 and March 7, 2028 and 1,218 on March 7, 2029.

Footnote F11

This represents the number of restricted share units for this transaction only. Mr. Weissman's aggregate remaining restricted share unit and common share balances following these transactions will be 11,253 and 36,205, respectively.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .